XML 94 R79.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity - Additional Information (Details) - USD ($)
12 Months Ended
Aug. 10, 2018
Jun. 14, 2018
Dec. 28, 2018
Dec. 29, 2017
Dec. 30, 2016
Feb. 11, 2016
Stockholders Equity Note [Line Items]            
Beneficial Ownership Percentage of Investor           26.00%
Allocated Share-based Compensation Expense     $ 6,762,000 $ 3,161,000 $ 8,558,000  
Weighted-average period of cost expected to recognize     2 years      
Estimated forfeiture rate     11.00%      
Proceeds from public offering of stock (in shares) 1,999,850          
Shares issued, price per share $ 36.309          
Proceeds from public offering of stock $ 72,150,000          
General and Administrative Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense     $ 2,635,000 1,487,000 3,809,000  
Selling and Marketing Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense     1,805,000 805,000 1,961,000  
Research and Development Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense     2,307,000 861,000 2,176,000  
Cost of Sales            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense     $ 15,000 $ 8,000 612,000  
Omnibus Equity Incentive Plan 2003            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         6,857,000  
Allocated share-based compensation expense would have been recognized         3,338,000  
Omnibus Equity Incentive Plan 2003 | General and Administrative Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         2,931,000  
Omnibus Equity Incentive Plan 2003 | Selling and Marketing Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         1,527,000  
Omnibus Equity Incentive Plan 2003 | Research and Development Expense            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         1,838,000  
Omnibus Equity Incentive Plan 2003 | Cost of Sales            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         561,000  
Omnibus Equity Incentive Plan 2003 | Restricted Stock And Restricted Stock Units            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         2,288,000  
Omnibus Equity Incentive Plan 2003 | Employee Stock Option            
Stockholders Equity Note [Line Items]            
Allocated Share-based Compensation Expense         $ 4,569,000  
Omnibus Plan            
Stockholders Equity Note [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized   2,235,000        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   15,385,000        
Omnibus Plan | Restricted Stock            
Stockholders Equity Note [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant     2,479,205